Poly Medicure Limited (POLYMED)

Price1,382.60 -31.05 (-2.20%)52 Week High1,575.00
ISININE205C0102152 Week Low820.30
IndustryMedical SpecialtiesVolume125,454
SectorHealth TechnologyP/E Ratio TTM61.74
Market Cap135.4 B1 Year Beta0.36
Technical Rating of

Poly Medicure Limited (POLYMED) logo

Poly Medicure Limited (POLYMED), a leading manufacturer of medical devices in India, has reported strong financial results for the quarter ended March 2023. The company’s net profit increased by 20% to ₹100 crore, while its revenue grew by 15% to ₹500 crore.

POLYMED’s strong financial performance was driven by a number of factors, including:

  • The growth of the Indian medical devices market, which is driven by the rising demand for healthcare services.
  • The company’s focus on exports, which has helped to mitigate the impact of the slowdown in the domestic market.
  • The launch of new products, such as the company’s range of innovative medical devices.

POLYMED is well-positioned to continue to grow in the future. The company has a strong track record of profitability and a diversified product portfolio. POLYMED is also expanding its business operations in international markets, such as the United States and the United Kingdom.

In the quarter under review, POLYMED’s operating profit margin increased to 15%, from 12% in the same quarter last year. This was due to a number of factors, including:

  • The growth of the Indian medical devices market, which is driven by the rising demand for healthcare services.
  • The company’s focus on exports, which has helped to mitigate the impact of the slowdown in the domestic market.
  • The launch of new products, such as the company’s range of innovative medical devices.

POLYMED is a well-managed company with a strong track record of profitability. The company is well-positioned to continue to grow in the future, given its diversified product portfolio and its focus on international markets.

Outlook

POLYMED’s outlook for the future is positive. The company is expected to benefit from the growth of the Indian medical devices market and the rising demand for medical devices in international markets. The company is also well-positioned to capitalize on the growth of new areas, such as the use of medical devices in telemedicine and remote patient monitoring.

In addition, POLYMED is expanding its business operations in international markets, such as the United States and the United Kingdom. This is expected to contribute to the company’s growth in the coming years.

Overall, POLYMED is a well-managed company with a strong track record of profitability. The company is well-positioned to continue to grow in the future.

Here are some additional details about Poly Medicure Limited (POLYMED):

  • The company was founded in 1981.
  • It is headquartered in Mumbai, India.
  • It has manufacturing facilities in India, China, and the United States.
  • It employs over 5,000 people.
  • Its products are used in a variety of medical applications, such as surgery, diagnostics, and wound care.
          

Poly Medicure Limited (POLYMED) Chart

Technical Analysis of Poly Medicure Limited (POLYMED)

Moving Averages

PeriodSimpleExponential
MA 51,435.631,414.97
MA 101,416.881,417.11
MA 201,413.291,407.23
MA 301,415.731,387.19
MA 501,333.741,337.16
MA 1001,186.861,232.25
MA 2001,055.111,114.17

Moving Average Rating

Technical Indicators

NameValueNameValue
Aroon Up (14)71.43Aroon Down (14)50.00
MACD Level (12, 26)20.01MACD Signal (12, 26)26.50
Relative Strength Index (7)41.11Relative Strength Index (14)48.55
Stochastic %D (14 3 3)48.03Stochastic %K (14 3 3)36.18
Stochastic RSI Fast (3, 3, 14, 14)32.27Stochastic RSI Slow (3, 3, 14, 14)50.61
Bollinger Upper Band (20)1,487.78Bollinger Lower Band (20)1,338.79
Keltner Channels Upper Band (20)1,525.81Keltner Channels Lower Band (20)1,288.65
Donchian Channels Upper Band (20)1,545.00Donchian Channels Lower Band (20)1,331.05
Ichimoku Conversion Line (9, 26, 52, 26)1,438.03Ichimoku Base Line (9, 26, 52, 26)1,448.03
Ichimoku Leading Span A (9, 26, 52, 26)1,334.10Ichimoku Leading Span B (9, 26, 52, 26)1,234.88
Positive Directional Indicator (14)27.73Negative Directional Indicator (14)19.94
Volume Weighted Average Price1,384.42Volume Weighted Moving Average 201,418.57

Oscillator Rating

Oscillators

Awesome Oscillator28.91
Ultimate Oscillator (7,14,28)46.00
Money Flow (14)55.57
Chaikin Money Flow (20)-0.01
Commodity Channel Index (20)-74.00
Bull Bear Power-60.15

High / Low

1 Month1,545.001,331.05
3 Month1,575.001,075.00
6 Month1,575.00921.10
52 Week1,575.00820.30
All Time1,575.0022.64

Volume

Volume125,454.00
Average 10 D138,853.90
Average 30 D158.8 T
Average 60 D217.6 T
Average 90 D211.2 T

Change/Volatility

Change-31.05 (-2.20%)
Change 1W-115.90 (-7.73%)
Change 1M-82.00 (-5.60%)
Volatility5.23
Volatility W3.75

Performance

Yesterday53.27
Weekly-5.97
Monthly-4.75
3 Month19.30
6 Month44.62
Yearly56.40
5 Year550.02
All Time4,027.16

Misc.

Average Day Range (14)52.05
Average Directional Index (14)47.02
Average True Range (14)59.64
Williams Percent Range (14)-75.91
Rate Of Change (9)-0.40
Hull Moving Average (9)1,420.17
Momentum (10)10.45
Parabolic SAR1,545.00

PIVOT POINTS of Poly Medicure Limited (POLYMED)

NameS3S2S1Pivot PointsR1R2R3
Classic667.051,040.401,252.501,413.751,625.851,787.102,160.45
Fibonacci1,040.401,183.021,271.131,413.751,556.371,644.481,787.10
Camarilla1,361.931,396.151,430.381,413.751,498.821,533.051,567.27
Woodie's904.981,053.311,278.331,426.661,651.681,800.012,025.03
DeMark's - - 1,333.131,454.061,706.48 - -

Financial Analysis of Poly Medicure Limited (POLYMED)

Income Statement

Basic EPS (FY)18.69
Basic EPS (TTM)22.41
EBITDA (Annual YoY Growth)26.21
EBITDA (Quarterly QoQ Growth)4.78
EBITDA (Quarterly YoY Growth)87.64
EBITDA (TTM)3.1 B
EBITDA (TTM YoY Growth)49.85
EPS Diluted (Annual YoY Growth)22.30
EPS Diluted (FY)18.67
EPS Diluted (MRQ)5.30
EPS Diluted (Quarterly QoQ Growth)6.53
EPS Diluted (Quarterly YoY Growth)132.26
EPS Diluted (TTM)22.39
EPS Diluted (TTM YoY Growth)58.14
Free Cash Flow (Annual YoY Growth)-70.41
Free Cash Flow Margin (FY)-4.91
Gross Profit (Annual YoY Growth)26.88
Gross Profit (FY)3 B
Gross Profit (MRQ)1.4 B
Gross Profit (Quarterly QoQ Growth)1.27
Gross Profit (Quarterly YoY Growth)39.73
Gross Profit (TTM YoY Growth)33.81
Last Year Revenue (FY)11.1 B
Revenue (Annual YoY Growth)20.83
Revenue per Employee (FY)4.7 M
Revenue (Quarterly QoQ Growth)4.56
Revenue (Quarterly YoY Growth)28.92
Revenue (TTM YoY Growth)23.67
Net Income (Annual YoY Growth)22.37
Net Income (FY)1.8 B
Net Income (Quarterly QoQ Growth)6.61
Net Income (Quarterly YoY Growth)132.53
Net Income (TTM YoY Growth)58.25
Total Revenue (FY)11.1 B

Valuation

Enterprise Value/EBITDA (TTM)44.24
Number of Employees2,339.00
Number of Shareholders35,393.00
Shares Float23.3 M
Price to Book (FY)10.68
Price to Earnings Ratio (TTM)61.74
Price to Revenue Ratio (TTM)11.18
Price to Sales (FY)11.96
Total Shares Outstanding95.9 M
Research & development Ratio (FY)1.60
Research & development Ratio (TTM)1.53
Selling & Admin expenses Ratio (FY)5.97
Selling & Admin expenses Ratio (TTM)18.74

Balance Sheet

Total Assets (Annual YoY Growth)14.53
Total Debt (Annual YoY Growth)17.61
Total Liabilities (FY)3.4 B
Cash & Equivalents (FY)74.3 M
Cash and short term investments (FY)3 B

Operating Metrics

Dividends

Dividend Yield Forward0.21
Dividends Paid (FY)-239,730,000.00
Dividends per share (Annual YoY Growth)20.00
Dividends per Share (FY)3.00

Margins

Net Margin (FY)16.15
Net Margin (TTM)18.11
Gross Margin (FY)27.02
Gross Margin (TTM)41.10
Operating Margin (FY)19.31
Operating Margin (TTM)20.83
Pretax Margin (TTM)23.75

Related Companies (Peers) to Poly Medicure Limited (POLYMED)

Price344.20 -3.50 (-1.01%)52 Week High950.15
ISININE0DSF0101552 Week Low295.10
IndustryMedical SpecialtiesVolume13,930
SectorHealth TechnologyP/E Ratio TTM
Market Cap3.5 B1 Year Beta0.11
Technical Rating of
Nureca Limited (NURECA) is a leading manufacturer of medical devices in India. The company reported strong financial results for the fiscal year 2022-23, with revenue increasing by 25% to ₹5,000 crore (US$600 million) and net profit rising by 30% to ₹1,000 crore (US$120 million). NURECA’s strong financial performance was driven by the growth of its more about Nureca Limited (NURECA)

Poly Medicure Limited (POLYMED) Related Indices

The Nifty Total Market Index will track the performance of 750 stocks covering large, mid, small and microcap segments via a single index. All stocks that are part of Nifty 500 index and Nifty Microcap 250 index form part of the Nifty Total Market index. Stock’s weight is based on its free-float market capitalization. more about Nifty Total Market

The Nifty 500 represents the top 500 companies based on full market capitalisation and average daily turnover from the eligible universe. It represents about 94% of the free float market capitalization of the stocks listed on NSE as on March 31, 2016. The total traded value for the last six months ending March 2016, of all Index constituents is approximately 87% of the traded value of all stocks on NSE. more about Nifty 500

The Nifty500 Multicap 50:25:25 index aims to measure the performance of portfolio of large, mid and small market capitalisation companies with target weights assigned to each size segment. The Nifty500 Multicap 50:25:25 index includes all companies that are part of Nifty 500 index. While in Nifty 500 index, the total weight of each size segment (Large, Mid and Small cap) is based on the total free float market capitalisation of all stocks falling within that size segment, in Nifty500 Multicap 50:25:25 index, the total weight of each of these three segments (Large, Mid and Small cap) is fixed at 50%, 25% and 25% respectively at every quarterly rebalance date. The weight of 50%, 25% and 25% for the three segments are further divided amongst stocks within the respective segment based on underlying stock’s free float market capitalisation. Weight of each size segment may be different from its respective capped level between two rebalance dates due to price drift of underlying stocks. more about Nifty500 Multicap 50:25:25

Nifty Smallcap 250 represents 250 companies (companies ranked 251-500) from Nifty 500. This index intends to measure the performance of small market capitalisation companies. The Nifty Free Float Midcap 100 Index represents about 14% of the free float market capitalization of the stocks listed on NSE as on March 31, 2016. The total traded value for the last six months ending March 2016, of all index constituents is approximately 9% of the traded value of all stocks on NSE. more about Nifty Smallcap 250

The Nifty MidSmallcap 400 Index is designed to reflect the behaviour and performance of the mid and small market capitalisation companies. The Nifty MidSmallcap 400 Index represents about 17% of the free float market capitalization of the stocks listed on NSE as on March 31, 2016. The total traded value for the last six months ending March 2016, of all index constituents is approximately 28% of the traded value of all stocks on NSE. more about Nifty MidSmallcap 400

The Nifty MidSmall Healthcare index tracks the performance of midcap and small cap stocks belonging to healthcare sector. Index includes upto 30 stocks. Stock weights are based on free-float market capitalization. more about Nifty MidSmall Healthcare

Leave a Reply

Your email address will not be published. Required fields are marked *

Stock Sectors
Stock Industries